Qiagen is a leading global provider of sample and assay technologies for molecular diagnostics, life science research, and applied testing. Its portfolio includes solutions for the isolation, purification, and analysis of nucleic acids and proteins from a wide range of biological samples. The company offers reagents, consumables, and automated instruments for PCR, qPCR, dPCR, and next-generation sequencing (NGS) workflows, supporting pathogen detection, genetic analysis, and biomarker discovery. QIAGEN products are used in clinical laboratories, pharmaceutical companies, and research institutions worldwide, enabling reliable, high-quality molecular testing and research. The company’s portfolio also includes advanced bioinformatics solutions.